FDA Drug recall D-0195-2025
Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-80…
- FDA Drug
- Class III
- ongoing
- Published 2025-01-22
On 2025-01-22 the FDA classified a Class III recall of Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-80… by Akron Pharma, citing labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0195-2025 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2024-12-12 |
| Published | 2025-01-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Akron Pharma |
| Distribution | US |
Product
Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.
Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Identifiers
| code_info | Lot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0195-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.